EyeGate Raises $22.6M In Venture Funding
The money will be used to further the company’s development of EGP-437 to treat dry eye syndrome.
The money will be used to further the company’s development of EGP-437 to treat dry eye syndrome.
TearLab Corporation has received FDA 510(k) clearance of its TearLab Osmolarity System.
Copyright © 2024 | WordPress Theme by MH Themes